Plant ID: NPO638
Plant Latin Name: Aralia fargesii
Taxonomy Genus: Aralia
Taxonomy Family: Araliaceae
NCBI TaxonomyDB:
45206
Plant-of-the-World-Online:
n.a.
China
OPRK1; | |
CA7; CA12; CA9; | |
ALOX15; HSD17B10; GFER; ALDH1A1; | |
CASP7; CASP1; | |
HIF1A; | |
XDH; |
Cytochrome P450 Enzymes: | CYP1A2; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Peptide receptor (family A GPCR) | OPRK1 | Kappa opioid receptor | P41145 | CHEMBL237 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.078E-07 | 1.919E-03 | CA12, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.679E-06 | 1.218E-02 | CA12, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 3.104E-06 | 1.690E-02 | CA12, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:1903715; regulation of aerobic respiration | 8.764E-06 | 2.726E-02 | HIF1A, OPRK1 |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 1.286E-05 | 3.405E-02 | ALDH1A1, ALOX15, CYP1A2, GFER, HSD17B10, XDH |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 2.045E-05 | 4.049E-02 | CASP1, CASP7, XDH |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.451E-07 | 5.224E-06 | CA12, CA7, CA9 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 3.896E-06 | 7.013E-05 | CYP1A2, XDH |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.568E-04 | 1.881E-03 | CYP1A2, ALOX15 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 7.657E-04 | 4.756E-03 | CYP1A2, ALOX15, ALDH1A1, HSD17B10, XDH |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 5.680E-04 | 4.756E-03 | CASP7, CASP1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 7.927E-04 | 4.756E-03 | CYP1A2, ALDH1A1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 1.054E-03 | 5.419E-03 | CASP7, CASP1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 5.148E-03 | 2.317E-02 | CASP7, HSD17B10 |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 3.643E-02 | 7.910E-02 | CASP1 |
09160 Human Diseases | 09161 Cancers | hsa05211 | Renal cell carcinoma | 4.207E-02 | 7.910E-02 | HIF1A |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |